|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||6.99 - 7.09|
|52-week range||6.99 - 7.09|
|Beta (5Y monthly)||1.40|
|PE ratio (TTM)||N/A|
|Earnings date||23 Feb 2022 - 28 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Altimmune, Inc. (ALT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Shareholders may be wondering what CEO Vipin Garg plans to do to improve the less than great performance at Altimmune...